Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Suzhou Basecare Medical Corp. Ltd. Class H ( (HK:2170) ) has provided an update.
Suzhou Basecare Medical Corporation Limited has announced the resignation of non-executive director Ling Yang, effective 15 January 2026, citing personal work arrangements. The board confirmed that his departure will not reduce the number of directors below the statutory minimum, and that Ling has no disagreement with the board nor any issues requiring disclosure to the stock exchange or shareholders, suggesting limited governance disruption and continuity in the company’s board oversight.
The most recent analyst rating on (HK:2170) stock is a Sell with a HK$2.00 price target. To see the full list of analyst forecasts on Suzhou Basecare Medical Corp. Ltd. Class H stock, see the HK:2170 Stock Forecast page.
More about Suzhou Basecare Medical Corp. Ltd. Class H
Suzhou Basecare Medical Corporation Limited is a China-incorporated medical company listed in Hong Kong, operating in the healthcare and medical technology sector. The company is governed by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical listed-company governance structure focused on compliance with PRC company law and Hong Kong listing requirements.
Average Trading Volume: 123,581
Technical Sentiment Signal: Sell
Current Market Cap: HK$599M
Find detailed analytics on 2170 stock on TipRanks’ Stock Analysis page.